We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nucleic Acid Tests for SARS, Chlamydia, Tuberculosis

By HospiMedica staff writers
Posted on 05 Nov 2003
Three new automated polymerase chain reaction (PCR) tests provide early detection of chlamydia, tuberculosis, and severe acute respiratory syndrome (SARS).

The SARS test (RealArt HPA coronavirus PCR kit), based on the highly sensitive real-time PCR technology, was developed by artus GmbH (Hamburg, Germany) in collaboration with the Bernhard Nocht Institute for Tropical Medicine in Hamburg. More...
Artus manufactures all three PCR tests, but under a marketing and distribution agreement with Abbott Laboratories (Abbott Park, IL, USA), Abbot has worldwide rights to market and distribute the three tests.

Through an alliance with Celera Diagnostics, Abbott also has the right to market and distribute the tests on the automated ABI Prism 7000 system. All three tests are available throughout the world, except in the United States, Canada, and Japan.

"Our fruitful collaboration with Abbott on the development and worldwide distribution of our ABI 7000-based RealArt kits has allowed us to accelerate the availability of these products,” said Thomas Grewing, representative managing director, artus.





Related Links:
artus GmbH
Abbott

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.